Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/35394 |
Resumo: | Solange C. Cavalcante. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento. |
id |
CRUZ_ddd39e1ab29937418d9684177fde12ab |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/35394 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Dowdy, David W.Golub, Jonathan E.Saraceni, ValeriaMoulton, Lawrence H.Cavalcante, Solange C.Cohn, SilviaPacheco, Antonio G.Chaisson, Richard E.Durovni, Betina2019-09-09T12:53:25Z2019-09-09T12:53:25Z2014DOWDY, David W. et al. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. Journal of Acquired Immune Deficiency Syndromes, v. 66, n. 5, p. 1-16, 2014.1525-4135https://www.arca.fiocruz.br/handle/icict/3539410.1097/QAI.00000000000002191944-7884Solange C. Cavalcante. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento.2020-09-09Johns Hopkins University. School of Medicine. Center for Tuberculosis Research. Baltimore, MA, USA / Johns Hopkins University. Johns Hopkins Bloomberg School of Public Health. Department of Epidemiology. Baltimore, MA, USA.Johns Hopkins University. School of Medicine. Center for Tuberculosis Research. Baltimore, MA, USA / Johns Hopkins University. Johns Hopkins Bloomberg School of Public Health. Department of Epidemiology. Baltimore, MA, USA.Municipal Health Secretariat. Rio de Janeiro, RJ, Brazil.Johns Hopkins University. Johns Hopkins Bloomberg School of Public Health. Department of International Health. Baltimore, MA, USA.Municipal Health Secretariat. Rio de Janeiro, RJ, Brazil / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Johns Hopkins University. School of Medicine. Center for Tuberculosis Research. Baltimore, MA, USAFundação Oswaldo Cruz. Presidência. Programa de Computação Científica. Rio de Janeiro, RJ, Brasil.Johns Hopkins University. School of Medicine. Center for Tuberculosis Research. Baltimore, MA, USA / Johns Hopkins University. Johns Hopkins Bloomberg School of Public Health. Department of Epidemiology. Baltimore, MA, USA / Johns Hopkins University. Johns Hopkins Bloomberg School of Public Health. Department of International Health. Baltimore, MA, USA.Municipal Health Secretariat. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. Rio de Janeiro, RJ, Brazil.Background —The potential epidemiological impact of isoniazid preventive therapy (IPT), delivered at levels that could be feasibly scaled up among people living with HIV (PLHIV) in modern, moderate-burden settings, remains uncertain. Methods — We used routine surveillance and implementation data from a cluster-randomized trial of IPT among HIV-infected clinic patients with good access to antiretroviral therapy in Rio de Janeiro, Brazil, to populate a parsimonious transmission model of TB/HIV. We modeled IPT delivery as a constant process capturing a proportion of the eligible population every year. We projected feasible reductions in tuberculosis (TB) incidence and mortality in the general population and among PLHIV specifically at the end of five years after implementing an IPT program. Results — Data on time to IPT fit an exponential curve well, suggesting that IPT was delivered at a rate covering 20% (95% confidence interval: 16%, 24%) of the 2,500 eligible individuals each year. By the end of year 5 after modeled program roll-out, IPT had reduced TB incidence by 3.0% (95% uncertainty range, UR: 1.6%, 7.2%) in the general population and by 15.6% (95%UR: 15.5%, 36.5%) among PLHIV. Corresponding reductions in TB mortality were 4.0% (95%UR: 2.2%, 10.3%) and 14.3% (14.6%, 33.7%). Results were robust to wide variations in parameter values on sensitivity analysis. Conclusions — TB screening and IPT delivery can substantially reduce TB incidence and mortality among PLHIV in urban, moderate-burden settings. In such settings, IPT can be an important component of a multi-faceted strategy to feasibly reduce the burden of TB in PLHIV.engLippincott, Williams & WilkinsImpact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological modelinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleTuberculosisInfectious disease transmissionHIVTheoretical modelsBrazilIsoniazidinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/35394/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALva_Dowdy_David_etal__INI_2014.pdfva_Dowdy_David_etal__INI_2014.pdfapplication/pdf896069https://www.arca.fiocruz.br/bitstream/icict/35394/2/va_Dowdy_David_etal__INI_2014.pdf205b6a22880a1bc728fb58efcdbd1e42MD52TEXTva_Dowdy_David_etal__INI_2014.pdf.txtva_Dowdy_David_etal__INI_2014.pdf.txtExtracted texttext/plain43359https://www.arca.fiocruz.br/bitstream/icict/35394/3/va_Dowdy_David_etal__INI_2014.pdf.txtcaadb7cabcf0e10e8a3e01ef4026dc15MD53icict/353942021-03-24 16:32:36.213oai:www.arca.fiocruz.br:icict/35394Tk9URTogUExBQ0UgWU9VUiBPV04gTElDRU5TRSBIRVJFClRoaXMgc2FtcGxlIGxpY2Vuc2UgaXMgcHJvdmlkZWQgZm9yIGluZm9ybWF0aW9uYWwgcHVycG9zZXMgb25seS4KCk5PTi1FWENMVVNJVkUgRElTVFJJQlVUSU9OIExJQ0VOU0UKCkJ5IHNpZ25pbmcgYW5kIHN1Ym1pdHRpbmcgdGhpcyBsaWNlbnNlLCB5b3UgKHRoZSBhdXRob3Iocykgb3IgY29weXJpZ2h0Cm93bmVyKSBncmFudHMgdG8gRFNwYWNlIFVuaXZlcnNpdHkgKERTVSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBEU1UgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgRFNVIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgRFNVIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gRFNVLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpEU1Ugd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-03-24T19:32:36Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model |
title |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model |
spellingShingle |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model Dowdy, David W. Tuberculosis Infectious disease transmission HIV Theoretical models Brazil Isoniazid |
title_short |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model |
title_full |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model |
title_fullStr |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model |
title_full_unstemmed |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model |
title_sort |
Impact of isoniazid preventive therapy for HIV-infected adults in rio de Janeiro, Brazil: an epidemiological model |
author |
Dowdy, David W. |
author_facet |
Dowdy, David W. Golub, Jonathan E. Saraceni, Valeria Moulton, Lawrence H. Cavalcante, Solange C. Cohn, Silvia Pacheco, Antonio G. Chaisson, Richard E. Durovni, Betina |
author_role |
author |
author2 |
Golub, Jonathan E. Saraceni, Valeria Moulton, Lawrence H. Cavalcante, Solange C. Cohn, Silvia Pacheco, Antonio G. Chaisson, Richard E. Durovni, Betina |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Dowdy, David W. Golub, Jonathan E. Saraceni, Valeria Moulton, Lawrence H. Cavalcante, Solange C. Cohn, Silvia Pacheco, Antonio G. Chaisson, Richard E. Durovni, Betina |
dc.subject.en.pt_BR.fl_str_mv |
Tuberculosis Infectious disease transmission HIV Theoretical models Brazil Isoniazid |
topic |
Tuberculosis Infectious disease transmission HIV Theoretical models Brazil Isoniazid |
description |
Solange C. Cavalcante. Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta a informação no documento. |
publishDate |
2014 |
dc.date.issued.fl_str_mv |
2014 |
dc.date.accessioned.fl_str_mv |
2019-09-09T12:53:25Z |
dc.date.available.fl_str_mv |
2019-09-09T12:53:25Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
DOWDY, David W. et al. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. Journal of Acquired Immune Deficiency Syndromes, v. 66, n. 5, p. 1-16, 2014. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/35394 |
dc.identifier.issn.pt_BR.fl_str_mv |
1525-4135 |
dc.identifier.doi.none.fl_str_mv |
10.1097/QAI.0000000000000219 |
dc.identifier.eissn.none.fl_str_mv |
1944-7884 |
identifier_str_mv |
DOWDY, David W. et al. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. Journal of Acquired Immune Deficiency Syndromes, v. 66, n. 5, p. 1-16, 2014. 1525-4135 10.1097/QAI.0000000000000219 1944-7884 |
url |
https://www.arca.fiocruz.br/handle/icict/35394 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Lippincott, Williams & Wilkins |
publisher.none.fl_str_mv |
Lippincott, Williams & Wilkins |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/35394/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/35394/2/va_Dowdy_David_etal__INI_2014.pdf https://www.arca.fiocruz.br/bitstream/icict/35394/3/va_Dowdy_David_etal__INI_2014.pdf.txt |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 205b6a22880a1bc728fb58efcdbd1e42 caadb7cabcf0e10e8a3e01ef4026dc15 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009263894724608 |